Compare Pfizer with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs VENUS REMEDIES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER VENUS REMEDIES PFIZER/
VENUS REMEDIES
 
P/E (TTM) x 32.2 -1.0 - View Chart
P/BV x 5.4 0.1 7,608.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   VENUS REMEDIES
EQUITY SHARE DATA
    PFIZER
Mar-18
VENUS REMEDIES
Mar-18
PFIZER/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs2,365126 1,878.5%   
Low Rs1,62561 2,659.6%   
Sales per share (Unadj.) Rs430.3301.8 142.6%  
Earnings per share (Unadj.) Rs78.7-24.9 -316.5%  
Cash flow per share (Unadj.) Rs93.22.5 3,662.1%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.5293.3 200.0%  
Shares outstanding (eoy) m45.7512.34 370.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.60.3 1,496.5%   
Avg P/E ratio x25.3-3.8 -674.2%  
P/CF ratio (eoy) x21.436.7 58.3%  
Price / Book Value ratio x3.40.3 1,067.0%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2711,154 7,910.6%   
No. of employees `0002.60.9 284.3%   
Total wages/salary Rs m3,143393 799.5%   
Avg. sales/employee Rs Th7,484.84,026.1 185.9%   
Avg. wages/employee Rs Th1,195.0425.0 281.2%   
Avg. net profit/employee Rs Th1,369.1-331.8 -412.6%   
INCOME DATA
Net Sales Rs m19,6853,724 528.6%  
Other income Rs m1,14323 5,079.6%   
Total revenues Rs m20,8283,747 555.9%   
Gross profit Rs m5,003395 1,267.2%  
Depreciation Rs m663338 195.8%   
Interest Rs m4354 1.2%   
Profit before tax Rs m5,479-275 -1,990.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,87832 5,944.3%   
Profit after tax Rs m3,601-307 -1,173.2%  
Gross profit margin %25.410.6 239.7%  
Effective tax rate %34.3-11.5 -298.7%   
Net profit margin %18.3-8.2 -222.0%  
BALANCE SHEET DATA
Current assets Rs m24,1672,638 916.2%   
Current liabilities Rs m9,5442,305 414.1%   
Net working cap to sales %74.38.9 830.7%  
Current ratio x2.51.1 221.2%  
Inventory Days Days55135 40.7%  
Debtors Days Days2946 62.0%  
Net fixed assets Rs m9,5144,871 195.3%   
Share capital Rs m458123 370.7%   
"Free" reserves Rs m26,3753,496 754.5%   
Net worth Rs m26,8323,619 741.4%   
Long term debt Rs m251,374 1.8%   
Total assets Rs m36,9007,509 491.4%  
Interest coverage x1,305.50.2 585,513.3%   
Debt to equity ratio x00.4 0.2%  
Sales to assets ratio x0.50.5 107.6%   
Return on assets %9.80.6 1,547.6%  
Return on equity %13.4-8.5 -158.2%  
Return on capital %20.41.6 1,290.5%  
Exports to sales %00-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m220-   
Fx outflow Rs m1,489517 288.2%   
Net fx Rs m-1,466-517 283.9%   
CASH FLOW
From Operations Rs m3,318514 645.0%  
From Investments Rs m-2,383-123 1,935.8%  
From Financial Activity Rs m-1,104-387 285.1%  
Net Cashflow Rs m-1694 -4,011.9%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 4,166.7%  
FIIs % 4.9 0.6 844.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 66.4 35.7%  
Shareholders   85,207 20,121 423.5%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 14, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS